Prowiz - I have been reading the "news articles" about the Nasdaq Biotechs - But most dont state all the facts.
It was down 6% but is now back up about 3% - The IBB index is not evenly weighted - Amgen and Gilead have a heavy weighting and Gilead sold off due to pressures on drug pricing.
Much prefer Biotech or more specifically ADO to mining or many other sectors at present.
ADO is broadly diversified within its business model and that is a major strength of which many are yet to appreciate IMO
technical update, page-143
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
